July 16, 2015, A-share listed company Boji Pharmaceutical (300404.SZ) announced to launch a 300-million-Yuan sized Health Care Industrial Investment Fund with Shenzhen Winning Venture Capital.  Boji Pharmaceutical (300404.SZ) is a leading domestic pharmaceutical CRO company covering pre-clinical, clinical trial service and R&D outsourcing service, while Shenzhen Winning Ventures is an emerging PE/VC firm expert in health industry investment. This fund is targeted to improve industry integration and promote company long term strategy of Boji Pharmaceutical. The investment target of this fund includes CRO, health care service, and health equipment, biotechnical and innovative pharm covering start-up stage, growth stage, Pre-IPO stage, mergers and acquisitions.